HIGHFDA DRUG

Lannett 10mg Dextroamphetamine Tablets Recalled for Foreign Tablet Contamination (2025)

Lannett Company Inc. recalls 4,848 bottles of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets. A bottle labeled 10 mg 100-count contained a 5 mg tablet. Two bottles were affected. Consumers and healthcare providers should stop using this product immediately. Contact Lannett or a healthcare provider for guidance.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
August 19, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
August 19, 2025
Hazard Level
HIGH
Brands
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Lannett Company
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
PREGNANT, GENERAL, PETS

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Lannett Company
Product type
Prescription Tablet
Model numbers
Lot#: 25283185A. Expiry: 02/28/2027
UPC codes
0527-0760, 0527-0761, 0527-0762, 0527-0763, 0527-0764, 0527-0765, 0527-0766, 0527-0760-37 +6 more
Sold at
Unknown
Where affected
OH

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    August 19, 2025

  2. Reported by FDA DRUG

    September 17, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Presence of Foreign Tablet/Capsule: Two (2) bottles labeled as Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, 10mg, 100ct, contained one (1) tablet of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, 5 mg.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Lannett Company Inc. or your healthcare provider for guidance. Notification method: Letter

About This Product

Dextroamphetamine tablets are prescription stimulants used to treat ADHD and narcolepsy. Medical supervision is required.

Why This Is Dangerous

A 10 mg bottle containing a 5 mg tablet alters prescribed dosage, risking under or overdosing depending on the patient's regimen.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Immediate action required; patients must stop use and consult a clinician to adjust therapy.

Practical Guidance

How to identify if yours is affected

  1. Verify bottle label shows Lot 25283185A and Expiry 02/28/2027.
  2. Confirm tablet strength is 10 mg per tablet as labeled.
  3. Check for any bottle labeled 10 mg, 100-count containing 5 mg tablets.

Where to find product info

FDA recall page and Lannett customer service for guidance.

What timeline to expect

Refund or replacement processing timelines vary; follow company instructions.

If the manufacturer is unresponsive

  • Document all contact attempts.
  • Contact FDA CFSAN recall contacts if the company is unresponsive.

How to prevent similar issues

  • Verify packaging integrity upon receipt.
  • Consult prescriber before using any dosage changes.
  • Keep medication in original packaging with lot numbers visible.

Documentation advice

Save recall notice, packaging, lot number, and any adverse event records.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Brand: Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate. Distributor: Lannett Company, Inc. Location: Philadelphia, PA 19136. NDC: 0527-0762-37. Quantity recalled: 4,848 bottles. Sold in OH. Classification: Class II. Expiry: 02/28/2027. Lot #: 25283185A.

Reported Incidents

No specific injuries or incidents are described in the recall notice. Information shows presence of foreign tablet in two bottles.

Key Facts

  • Foreign tablet in 2 bottles
  • 10 mg labeled bottles contained 5 mg tablets

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
PREGNANTGENERALPETS
Injury Types
POISONINGELECTRICAL

Product Details

Model Numbers
Lot#: 25283185A. Expiry: 02/28/2027
UPC Codes
0527-0760
0527-0761
0527-0762
+11 more
Affected States
OH
Report Date
September 17, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more